Lisata Therapeutics adopts 2026 Equity Incentive Plan
Lisata Therapeutics filed an 8-K introducing its new 2026 equity incentive plan covering officers, employees, and consultants, effective as specified.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed